Hesingue, Switzerland

Francois Natt

This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francois Natt. Retrieved from https://idiyas.com/inventor/francois-natt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Francois Natt in Influenza Research

Introduction

Francois Natt is a notable inventor based in Hesingue, Switzerland. He has made significant contributions to the field of virology, particularly in the study of influenza viruses. His innovative work has led to the development of methods that enhance our understanding of virus reassortment.

Latest Patents

Francois Natt holds a patent related to influenza virus reassortment. The patent focuses on methods for producing reassortant viruses, wherein the transcription and/or translation of the hemagglutinin and/or neuraminidase genes are suppressed. This innovation is crucial for advancing research in vaccine development and understanding viral behavior.

Career Highlights

Francois Natt is associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in virology. His dedication to scientific advancement is evident in his patent and ongoing research efforts.

Collaborations

Francois has worked alongside notable colleagues such as Heidi Trusheim and Peter W. Mason. Their combined expertise has fostered a collaborative environment that promotes innovative solutions in the study of influenza viruses.

Conclusion

Francois Natt's contributions to influenza research through his patent and work at Novartis AG highlight the importance of innovation in the field of virology. His efforts continue to pave the way for advancements in understanding and combating viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…